Serenno Medical For Profit
Serenno Medical is a company that offers a pioneering Urine Output (UO) Monitor for hospitalized patients, improving Acute Kidney Injury (AKI) prediction and fluid management. AKI is a dangerous and common complication that affects 19 million patients worldwide every year. The company's system provides continuous urine output measurement, which is the only reliable way to detect, assess, and possibly anticipate AKI occurrence. The Serenno system is fully automatic, low workload, hands-free, EMR connected, delivering more actionable data, safe, robust, and reliable for every patient. It is low cost, easy to use, and can be streamlined into the ICU. The company has won several awards and is supported by the EIT. Contact info: N/A.
Founded Date:
2017-01-01
Headquarters:
Yoqne`am `illit, HaZafon, Israel
Technology:
Biomarker panels
Employee Number:
N/A
Industry:
Clinical Data Management
Number Of Exists:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A